Join us at the Wig and Pen pub on the 2nd of November 2018 at 18.00 to learn more about the program and meet our program mentors.
John has an intriguing job of Chief scientist and innovation (investment opportunity) seeker for SOSV (Sean O Sullivan Ventures), one of the world’s most active early stage investors. His principal interests within the firm are bioscience investments which are developed in RebelBio, a dedicated investment program recently established by Dr Carrigan and his team at Imperial College White City. Dr Carrigan began his career as an academic biochemist where he published papers concerning protein chemistry and metabolomics. Subsequently he went into the world of start ups with Dublin based AERBIO, which was acquired by green biochemical company Cellulac ltd in 2013. Away from his work with SOSV, he acts as an expert advisor for the European Innovation Council‘s SME (Small Medium Enterprise) instrument–an initiative to fund the most promising start up bioscience companies across Europe.
Philippa is a Licensing and Ventures Manager at Oxford University Innovation (OUI) in the Digital Health and Medical Devices team. She has worked for the past three years with researchers across the University of Oxford to help them create impact with their ideas. Philippa has expertise in developing early stage ideas into business propositions, which includes IP landscape analysis, market analysis, building business plans, CE marking and regulatory issues, advice on app development, and licence negotiations. Whilst a large number of her projects are in the digital health space, Philippa has facilitated spinout companies from the Humanities and Social Sciences Divisions. She is delighted to be increasingly working with projects focused on mental health issues.
Philippa also has a passion for social enterprises, companies that put purpose before profit, and is part of the team offering a support to create these entities from the University. Philippa was part of the team that set up OxReach, the crowdfunding platform for social good projects from the University of Oxford. She has supported four successful campaigns which have all benefited substantially from the public support that they received and are now creating local and international impact
David is a social entrepreneur and experienced technologist with a passion for innovation in healthcare and specifically paediatrics. He has had a career with IBM spanning nearly 20 years and has spent the last three years working within IBM’s artificial intelligence arm, Watson. David began the role of Innovation and AI Lead at the beginning of 2018 with the remit of exploring new ways for healthcare organisations to embrace IBM’s healthcare and Cognitive technologies.
Outside of IBM, David runs a UK based children’s charity, Thinking of Oscar, which supports children and their families whilst in hospital care, funding innovation and technology over and above that provided by the UK health services. Thinking of Oscar was set up following the sudden death of his son Oscar in 2014 and has raised over £200,000. David and his wife Hannah work closely with UK Children’s hospitals to identify projects where they can make a difference. David is a member of The International Society for Paediatric Innovation (iSPI) which has been formed to address the unmet needs of an open global network, enabling unique opportunities for paediatric leaders to be at the cutting edge of technological innovations. His ultimate goal is to see artificial intelligence technologies, such as Watson, pervasively used in paediatric healthcare to assist with knowledge share, decision making and ultimately save lives.
David is a ‘Digital Health Expert in Residence’ at the University of Oxford supporting its healthcare start-up incubator, The Hill. David is also an advisor to a number of boards and faculties looking at health technology, child health and the future of medicine. David lives in rural Oxfordshire in the UK, with his wife and 3 young children. David is a keen triathlete, cricketer and wine enthusiast, holding an Advanced Level 3 qualification from the Wine and Spirit Education Trust. He is building up to compete in his first full Ironman in July 2019.
Tony is the Head of Smart Oxford, Oxford’s smart city project. Tony has been working with technology innovation companies and start-ups across Oxfordshire and the UK for the past 15 years, having worked for and with major technology companies in the US, Europe, India and China. Recently he was the Managing Director of the UK subsidiary of Holley Technology, the leading Chinese smart meter manufacturer based in Hangzhou.
He has a strong focus and ability at identifying and bringing to market (commercialising) technology solutions within both corporate and entrepreneurial (start-up) environments. Tony has an MA in Engineering & Economics from the University of Oxford and an MBA from Henley Management School.
As Managing Director of Triteq, a product design consultancy, Angela is continuously connected to new ideas, creative talent and amazing people. She learns something new every day.
In a school essay entitled “What do you want to be when you grow up” – Angela explained why she wanted to be a Judge. Many years later, she received an invitation to join the Design Council as a Judge on the Tech Spark competition: reviewing amazing pitches from innovative start-ups and helping to select those with the qualities to succeed. It was a privilege for Angela to be involved…and it even fulfilled her long time judging ambition!
As a NED, Angela also works with Intelligent Horsemanship, a company that helps horses and their humans to get the most out of their relationships. Kelly Marks, the Founder, taught her to ride racehorses and trained me to deal with the challenges of a horse riding trip across the Mongolian Steppes. Angela is currently planning her next adventure.
Brian has had a long and successful career as medtech business leader in large corporations, AIM listed companies and early stage ventures. He was CEO of Lombard Medical Technologies (2005 – 2009) and General Manager of Boston Scientific in UK (1999 – 2005). Brian is currently a board member of three emerging medtech companies, including Oxford Endovascular.
Keith is an investor in, and advisor to, a portfolio of companies principally in the data and scientific fields. Keith earned his PhD in Astrophysics from Cambridge University in 1992, studying the early chemical evolution of the Universe, and then turned his focus to applying the same scientific techniques to financial data by setting up a proprietary trading firm to trade the markets.
He is a founding partner of Elixir Ventures, investing and working with early and mid stage innovative companies.
Sarah has inspired others to achieve leadership performance through theatre teaching, psychotherapy, coaching and training for the past 40 years. She has worked with teenagers, adults, ex-prisoners and senior executives.
These days, as well as being co-founder of STEMM Commercial, Sarah trains and coaches leaders with a STEMM background to win influence, advancement and stakeholder buy-in. She works in not-for-profit organisations such as the Stockholm Environment Institute as well as in commercial organisations such as Cisco, Skanska and Astrium (EADS) and SMEs. In partnership with Oxford University’s Institute of Biomedical Engineering, she has designed and delivered programmes for STEMM doctoral researchers to attract engagement and buy-in at conferences, develop business awareness and improve their interview skills to advance their innovation.
Nick is the Digital Innovation & Population Health Lead at Oxford University Hospitals NHS FT. He is responsible for development of digital health innovation pathways, launching open interoperability (SMART on FHIR) solutions and leading the implementation of a regional digital population health systems across Oxfordshire. Nick is a Board member of Thames Valley & Surrey Local Health and Care Record Exemplar (LHCRE) programme (integrating health and care for population of 3.8M people), and represents the programme on NHS England’s Clinical Advisory Group.
Nick is also an NHS England Clinical Entrepreneur, building on his work as the founder and CEO of Ufonia, a digital health start-up company developing voice-based robotic-process-automation for the management of long-term conditions. He is one of the founders of TheHill, a European Union funded digital health innovation lab working with members of the Oxford Academic Health Science Network (AHSN) to help identify needs, support innovators, incubate businesses and accelerate access to the Oxford health ecosystem.
Nick obtained his CCT in Neurosurgery in 2015 having been a specialist registrar at Oxford University Hospitals NHS FT. Prior to this he studied undergraduate medicine at Cambridge University and clinical medicine at Oxford University.
James has worked with a variety of largely corporate clients, including start-ups, SMEs, international companies and groups, and publicly listed companies. James has experience working in a wide range of sectors but with particular emphasis on science / technology companies. He has worked closely with entrepreneurs, academics, research institutions and companies from spin out through to listing on accounting, taxation and strategic issues. He is delighted to offer advice and guidance for the programme.
With offices in the South of England, membership of Kreston International and a global network of independent accountants and business advisers, James Cowper Kreston is ideally placed to provide informed local, national and international advice.
Paul has over 15 years experience as an entrepreneur, investor and active supporter of early stage businesses. His professional background spans the military, tourism, hospitality, finance, asset management and technology. He has worked with Goldman Sachs, Freeman, Imperial Innovations, and Generation Asset Management a $1.4 billion asset management business. Paul co-founded Fuel Ventures, a London-based seed venture capital fund and active accelerator focusing on early stage digital businesses, which he exited in 2016.
Marc is an economic sociologist in the Strategy, Innovation and Marketing Faculty at Saïd Business School and a Governing Body Fellow of Wolfson College. His teaching focuses on strategy and innovation, implementation, and entrepreneurial leadership and leadership for complex operations. At Oxford, he is Academic Director for the Science Innovation Plus initiative, support many student and research activities for the Skoll Centre for Social Entrepreneurship, and serve as a core faculty member for the Goldman Sachs 10K Women Entrepreneurs Programme in China. He is advisor/mentor to five startups founded by recent Oxford alumni, and a strategic advisor for Oxford Entrepreneurs, Global Thinkers Forum, Local Insight/Global Impact, and the Oxbridge Biotechnology Roundtable. He is recently supported an MBA team working with the World Economic Forum Global Agendas Councils. Marc does custom executive education with a range of global firms, public sector organisations, and civil society agencies.
Elen is responsible for planning all aspects of the BioEscalator, the new incubator currently being built at Old Road Campus. The BioEscalator will house small and growing medical science companies that are working with Oxford researchers to take innovative ideas from the lab to the clinic. It will also be a hub for bioscience collaboration in Oxford.
Elen’s background is in research, commercialisation of research and supporting early-stage entrepreneurs. She has worked at MIT, Oxford University Innovation, Begbroke Science Park and the Saïd Business School.
IMAGINE IF! is an unmissable opportunity for science entrepreneurs to nurture their early-stage HEALTH & LIFE sciences focused idea in a program that is: